Clinical Trial Update: An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating PF-04383119 for effectiveness and safety in treating pain associated with interstitial cystitis; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystitis
• Interstitial Cystitis

Drugs mentioned

• PF-04383119

Snippet

Sponsor: Pfizer | Conditions: Cystitis, Interstitial | Phase 2 | Status: COMPLETED | Results posted: 2021-05-13